The People section provides a directory of all scientific, technical/administrative, internal control, and risk management staff at IIT. This enables you to get in touch with staff and learn about their professional skills within IIT. Your profile will remain on People for five years after the termination of your relationship with IIT. If you do not wish to appear on People, you can contact the IIT Data Protection Officer (whose details can be found in the "Privacy" section of the website) to request the removal of your profile.
EDUCATION / WORK EXPERIENCE
2019- present: Tenured Senior Researcher, Neuroscience Area, Istituto Italiano di Tecnologia, Genova, Italy.
2013- present: Adjunct Faculty Investigator, Lieber Institute for Brain Development. Baltimore, MD, USA.
2014- 2019: Senior Researcher, Associate Professor level, Neuroscience and Brain Technologies Department, Istituto Italiano di Tecnologia, Genova, Italy.
2011- 2014: Assistant Professor, Department of Pharmacological Sciences, University of Padova, Italy.
2010- 2014: Tenure Track-1, Team Leader, Neuroscience and Brain Technologies Department, Istituto Italiano di Tecnologia, Genova, Italy.
2005- 2010: Post Doctoral Fellow, Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, USA. Supervisors: Dr. Daniel R. Weinberger and Dr. Jacqueline N. Crawley.
2004- 2004: Researcher, University of Bordeaux, France. Supervisors: Prof. Antoine Tabarin and Dr. Angelo Contarino.
2003- 2004: Researcher, INSERM Unit 588, “Laboratoire de Physiopathologie du Comportement”, Bordeaux, France. Supervisors: Dr. Pier Vincenzo Piazza and Dr. Angelo Contarino.
2002- 2005: PhD Student in Pharmacology and Toxicology, University of Padova, Italy. Supervisor: Dr. Angelo Contarino.
2000- 2001: Pharmacist. S. Chiara pharmacy. Vicenza, Italy. Supervisor: Dr. Paolo Pretto.
1996- 2001: Pharmacy graduate studies (110/110 cum Laude), University of Padova, Italy.
GRANTS
2022- 2025: Co-PI, work package leader. AIFA (Agenzia Italiana del Farmaco). Title: “Cannabidiol as an add-on treatment to substance abuse in juvenile patients with psychosis: a double-blind randomized placebo-controlled study (CAT-PSY)”.
2020- 2022: Principal Investigator. Research collaboration agreement with Friedrich Miescher Institute for Biomedical Research, Switzerland. Title: “Use of an innovative conditional D2-receptor knockout approach, coupled to time- and cell type-specific viral delivery to identify the critical targets in the mouse model LgDel”.
2020- 2024: Principal Investigator. Fondazione Telethon – project GGP19103, title: “Improving developmental trajectories in 22q11.2 deletion syndrome by oxytocin: focus on anti-inflammatory effects”.
2018- 2023: Principal Investigator. Ricerca Finalizzata Giovani Ricercatori 2016 - Ministero Salute – project GR-2016-02362413, title: “Dysbindin-antipsychotics psychophamarcogenetics: a mouse-human translational study towards personalized healthcare in bipolar disorders”.
2018- 2021: Principal Investigator. Boehringer Ingelheim Pharma. Title: “Role of the frontocortical-parvalbumin system in higher-order cognitive functions and in the onset of cognitive deficits induced by schizophrenia-relevant mutations”.
2018- 2020: Supervisor and hosting lab. Marie Sklodowska-Curie individual Fellowships to Celine Devroye. Grant N. 796244. SocialBrainCircuits.
2018: Principal Investigator. The MINDDS Action of the European COST Association (eCOST). Training school/hands-on workshop in “Convergence Neuroscience: bridging the gap between human patients and animal models of neurodevelopmental disorders”.
2016- 2018: Principal Investigator. Compagnia di San Paolo grant n. 2015-0321. Title: “Utilizzo di variazioni genetiche in dysbindin-1 (dtnbp1) per lo sviluppo di trattamenti più efficaci e personalizzati per la schizofrenia”.
2015- 2018: Principal Investigator. Brain & Behavior Research Foundation, 2015 NARSAD Independent Investigator grant n. 23234; Title: “Use of genetic-driven dysbindin-1 (DTNBP1) variations for more effective and personalized treatments in First Episode of Psychosis”.
2013- 2017: Principal Investigator. Roche Postdoc Fellowship Program; title: “D2L/S-dysbindin genetic interaction: towards early detection and personalized interventions for cognitive deficits and schizophrenia”.
2014- 2015: in charge of a work package. 2013 NARSAD Young Investigator grant. Title: “Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11 microdeletion syndrome genetically at high risk for psychosis: A randomised, double blind, placebo-controlled treatment trial”.
2013- 2016: Principal Investigator. Ricerca Finalizzata Giovani Ricercatori 2010 - Ministero Salute – project GR-2010-2315883, title: “Schizophrenia pathogenetic mechanisms associated to dysbindin dysfunctions in fly and mouse models”.
2008- 2010: Principal Investigator. NIHM Julius Axelrod Memorial Fellowship Training Award. Behavioral characterization of genetically modified mice for schizophrenia-associated susceptibility genes.
AWARDS AND HONORS
2018: Abilitazione Scientifica Nazionale, Full Professor, Fascia 1, Pharmacology.
2018: Scientific Director and Organizer of the Training school/hands-on workshop in “Convergence Neuroscience: bridging the gap between human patients and animal models of neurodevelopmental disorders”. Genova, Italy.
2017: travel award, ACNP 56th Annual Meeting, USA.
2017: Scientific Director and Organizer of the International Summer School of Neuroscience. Noto, Italy.
2015: Spring 2015 JOVE/Med Associates Competition.
2014: the Marie Curie Alumni Association.
2012: Winter Conference on Brain Research Travel Fellowship Award.
2009: Award as Preceptor, Howard Hughes Medical Institute Student Internship Program.
2008: NIMH Julius Axelrod Memorial Fellowship Training Award.
2008: Award as Preceptor, Howard Hughes Medical Institute Student Internship Program.
2007: Mentor to prize winner, American Academy of Neurology, Neuroscience Research Prize.
PROFESSIONAL SOCIETIES & SCIENTIFIC COMMITTEE
2018- : The Association for the Study of Animal Behaviour
2013- : Societa' Italiana di Farmacologia
2012- : Schizophrenia International Research Society
2012- : The Marie Curie Alumni Association
2008- : International Behavioral Neuroscience Society
2004- : Society for Neuroscience
2021- : Scientific Programme Committee, European College of Neuropsychopharmacology (ECNP)
2020- : Scientific Committeee of the IIT IACUC (Institutional Animal Care and Use Committee).
Title: PhD Student in Pharmacology
Institute: University of Padova and University of Bordeaux
Location: Padova & Bordeaux
Country: Italy & France
From: 2002 To: 2005
Title: Pharmacy graduate studies
Institute: University of Padova
Location: Padova
Country: Italy
From: 1996 To: 2001
Title: Post Doctoral Fellow
Institute: National Institute of Mental Health, NIH
Location: Bethesda
Country: USA
From: 2005 To: 2010